Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of HuMoSCs on Glandular Involvement in Sjögren's Syndrome
NCT07861828Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Single-arm trial in Sjögren's syndrome, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoints: Percentage of the various subclasses of lymphocytes and macrophages at 24 months and Concentrations of inflammatory and anti-inflammatory cytokines at 24 months. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT07861828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07861828.